Billy Evans, partner of Theranos founder Elizabeth Holmes, is raising money for his startup, Haemanthus, focused on diagnostics. Reports indicate he has garnered several million dollars for this venture, which aims to analyze blood, sweat, and urine to identify diseases. After Holmes's fraud conviction, skepticism surrounds Evans's efforts. Haemanthus publicly distanced itself from Theranos, stating on social media that it is committed to legitimate diagnostics, emphasizing transparency and its own distinct technologyâwhile acknowledging the rationality of public skepticism given the previous scandals associated with Theranos.
"Skepticism is rational, given the historical context. However, we want to assure our investors that this is not Theranos 2.0; we're pursuing legitimate diagnostics."
"Haemanthus is focused on building innovative tools to analyze biological material for disease detection, emphasizing integrity and transparency in our approach."
Collection
[
|
...
]